Effect of training-sample size and classification difficulty on the accuracy of genomic predictors
about
Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisA simple but highly effective approach to evaluate the prognostic performance of gene expression signaturesDiscovering biological connections between experimental conditions based on common patterns of differential gene expressionA systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancerThe MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.Optimising parallel R correlation matrix calculations on gene expression data using MapReduce.High dimensional biological data retrieval optimization with NoSQL technology.Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypesObesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancerPredicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER statusBuilding prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response.Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems.A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancerClaudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationStatistical measures of transcriptional diversity capture genomic heterogeneity of cancer.Predicting response and survival in chemotherapy-treated triple-negative breast cancer.Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial.Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.Pathway activity inference for multiclass disease classification through a mathematical programming optimisation framework.Effects of sample size on differential gene expression, rank order and prediction accuracy of a gene signatureMicroarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreementDetermination of minimum training sample size for microarray-based cancer outcome prediction-an empirical assessment.Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.Differential network analysis applied to preoperative breast cancer chemotherapy response.Current composite-feature classification methods do not outperform simple single-genes classifiers in breast cancer prognosis.ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.Evaluation of gene expression classification studies: factors associated with classification performanceEvaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive valueA gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistanceA breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables.A three-gene model to robustly identify breast cancer molecular subtypesNotch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.Study design requirements for RNA sequencing-based breast cancer diagnosticsBreast cancer subtype predictors revisited: from consensus to concordance?Characterization of DNA variants in the human kinome in breast cancer.PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.
P2860
Q28545978-9CABC08A-8465-4C77-AE2D-03F41711D2EDQ28741755-D9F037CD-2872-4D17-AC33-EF510CEAE703Q28743395-BDD9CAAC-6DFA-4D37-9AC0-D7D93AD9E671Q30423830-97E71973-F2F1-472E-90D6-144E7454B9C4Q30487036-262B3D44-12CC-4EDA-86C3-145210D46228Q30512428-B74BD67C-3AA2-4D5D-9B6C-01C53DD0CB29Q30867604-2D18B6A5-566B-4AE0-B796-48321A4EF79AQ30872534-FC715391-0A8D-4EC8-9CD3-92F11607D214Q31151786-3AB9A4FA-835A-4FF8-8F59-368DAD8A1DD5Q33567263-CF436041-FD5C-4AD5-83DB-77083D6A0478Q33751916-2710970F-347F-40CB-B89F-189F933441AEQ33769803-60E188BD-47CB-4E6C-9FE2-68C5ED7B362CQ33788520-76D9DA71-D08A-4B72-BADB-2D13D340194BQ33974305-97C76694-CC13-4C05-809C-0B27781A065AQ34088408-5C8B390B-B846-4292-949A-B2356C2B21FBQ34256229-846B11A5-011D-4524-A592-29FC378D9D06Q34339847-06F23686-8766-4C66-A1AB-7D4BA86BAFA5Q34339885-2E959400-745A-42EF-AB30-3EB42A7B248DQ34354538-AD22A127-4C07-4698-82F0-553E14BBB990Q34480023-276EAF83-D803-4AEB-A674-36FF566361E1Q34558758-580F1FEF-F5F3-426A-9F52-CAD21722DCDDQ34721895-0062522A-FB14-4169-8B76-734731CABBBAQ34766433-C31EA4D2-2F08-40D2-86BD-F380D149DA29Q34820314-00E89202-3F03-45A8-9CF3-60CA5AB8B8C2Q34827732-F6723454-20D0-495D-ABE4-7896BC1F0C48Q35000651-5983D533-3673-4F4A-8FAF-9FE30DEF2320Q35000662-16613F39-4891-44AB-8D9C-659BB2116372Q35069778-404A1521-9F77-4505-A365-0F63D4491801Q35082280-C673F312-64B9-45B5-AA4F-2C3DDFF5B165Q35155403-C5C8B7DE-C12B-46CF-8772-9885E228C5CEQ35158226-8DD1551E-8C6F-4757-A4B3-A51813AC55D7Q35503492-68E57B3E-0EAF-451C-ABCE-C8C34664BCFEQ35566213-981BBD09-F901-4EF3-B597-57114C597611Q35640223-0E6C4C96-B48C-4F04-94E3-6041698AB29AQ35769036-C08ED58F-7CC6-4BED-A726-2F8DB5A004B9Q35836089-18B9D49F-03E4-47C0-A5FC-E924A3D48A00Q35910164-6F0C1A2C-ACFE-4F45-A20B-540E9DD547A3Q36040448-CE9CCAD4-37D6-420C-96C4-DCB37AC61615Q36106656-A1B671BB-E0A3-4959-AA24-3A4E67430AB5Q36147185-D096A0C4-941A-484E-A009-0001A5A4589D
P2860
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of training-sample size ...... accuracy of genomic predictors
@ast
Effect of training-sample size ...... accuracy of genomic predictors
@en
type
label
Effect of training-sample size ...... accuracy of genomic predictors
@ast
Effect of training-sample size ...... accuracy of genomic predictors
@en
prefLabel
Effect of training-sample size ...... accuracy of genomic predictors
@ast
Effect of training-sample size ...... accuracy of genomic predictors
@en
P2093
P2860
P50
P356
P1476
Effect of training-sample size ...... accuracy of genomic predictors
@en
P2093
Alex Ishkin
Daniel Booser
Frank W Samuelson
Gabriel N Hortobagyi
Kenneth R Hess
Lajos Pusztai
Leming Shi
Marina Tsyganova
Mauro Delorenzi
Tatiana Nikolskaya
P2860
P2888
P356
10.1186/BCR2468
P577
2010-01-11T00:00:00Z
P5875
P6179
1031024054